Role of Etomidate in Critical Care for Rapid Sequence Intubation

Published on:June 2020
Indian Journal of Pharmacy Practice, 2020; 13(2):113-116
Review Article | doi:10.5530/ijopp.13.2.17

Role of Etomidate in Critical Care for Rapid Sequence Intubation

Authors and affiliation (s):

Vishnu Kumar*, Ajay K Raj, Rasha Mahroof, M Fabin, Ansil M

KMCT Medical College, Manassery, Mukkam, Kozhikode, Kerala, INDIA.


Rapid sequence intubation is a process involving the administration of a sedative induction agent and a paralytic agent to facilitate endotracheal intubation. Administration of an induction agent followed by a rapidly acting neuromuscular blocking agent to produce unconsciousness and motor paralysis provide optimal intubation condition and protect the patient’s airway. Etomidate is gamma amino butyric acid agonist administered to facilitate a state of unconsciousness; it has a rapid onset of action and duration of action for 4-10 min, minimal cardiovascular effects, respiratory depression of histamine release and provides protection from myocardial and cerebral ischemia. This review discuss the importance of Etomidate as the first line induction agent in emergency department. A detail literature review of rapid sequence intubation in emergency department was carried out from PubMed using the keywords Etomidate, Ketamine, Propofol, Rapid sequence intubation. Etomidate is the first line drug in thermodynamically stable patients and in traumatic brain injury. However, it should not be used as an infusion or as repetitive bolus doses for maintenance dosage adjustment in elderly patients. Etomidate when used provides sedation within 1 min and eliminates critical monitoring requiring only basic monitoring parameters like blood pressure, pulse and ECG readings. Incidence of hypotension is low and when occurs can be managed with IV fluids, the sedation lasts for about 30 mins. However patient specific factors must also be considered during the selection of intubating agent.

Key words: Rapid, Sequence intubation, Etomidate, Ketamine, Propofol, ECG changes.


The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.


IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs